INdividualized ITI Based on Fviii(ATE) Protection by VWF

NCT03204539 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Termination of funding from sponsor.

Conditions

Hemophilia A With Inhibitor
Hemophilia A

Interventions

DRUG: Wilate

Sponsor

University of California, Davis